Meeting
2023 ASCO Genitourinary Cancers Symposium
Pathogenic BRAF mutations in prostate cancer: Frequency and distribution.
Authors
Elisa M. Ledet
Tulane University, New Orleans, LA
Elisa M. Ledet , Elizabeth Mauer , Calvin Y. Chao , A. Oliver Sartor
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 257)
DOI
10.1200/JCO.2023.41.6_suppl.257
Abstract #
257
Poster Bd #
J14
Abstract Disclosures
Similar Posters
Poster
2018 Genitourinary Cancers Symposium
Cell-free DNA (cfDNA) analysis and evaluation of BRAF amplifications and mutations in metastatic castration-resistant prostate cancer.
First Author: Peter Steinwald
Poster
2018 Genitourinary Cancers Symposium
Detection of actionable BRAF missense mutations by ctDNA-based genomic analysis in prostate cancer.
First Author: Malshundria Prophet
Poster
2018 Genitourinary Cancers Symposium
Cosegregation of cfDNA AR amplifications and mutations in relation to BRAF and MYC in CRPC.
First Author: Bryce Raymon Christensen
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Impact of acquired RAS, BRAF and PIK3CA mutation at 8 weeks on the efficacy of anti-EGFR monoclonal antibodies in metastatic colorectal cancer.
First Author: Takeshi Yamada